|
No records
|
|
642 |
23473513200 |
Kuntjoro Harimurti |
Dr. dr. Kuntjoro Harimurti, Sp.P.D-KGer., M.Sc. |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Clinical Evaluation of HIV/AIDS Patients on Antiretroviral Therapy using HIV Symptoms Index: A reliability and Applicability Evaluation using Indonesian Language |
Shidiq K.M., Nelwan E.J., Yunihastuti E., Harimurti K., Pohan H.T. |
Acta medica Indonesiana |
|
Q3 |
|
|
|
648 |
23473513200 |
Kuntjoro Harimurti |
Dr. dr. Kuntjoro Harimurti, Sp.P.D-KGer., M.Sc. |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
The Association of ?2-Microglobulin and Fibroblast Growth Factor 23 with Major Adverse Cardiac Event in Acute Coronary Syndrome Patients with Chronic Kidney Disease |
Ginanjar E., Alwi I., Lydia A., Immanuel S., Yamin M., Indrajaya T., Harimurti K. |
Acta medica Indonesiana |
|
Q3 |
|
|
|
696 |
23473513200 |
Kuntjoro Harimurti |
Dr. dr. Kuntjoro Harimurti, Sp.P.D-KGer., M.Sc. |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Streptococcus pneumoniae carriage and antibiotic susceptibility among Indonesian pilgrims during the Hajj pilgrimage in 2015 |
Harimurti K., Saldi S.R.F., Dewiasty E., Alfarizi T., Dharmayuli M., Khoeri M.M., Paramaiswari W.T., Salsabila K., Tafroji W., Halim C., Jiang Q., Gamil A., Safari D. |
PLoS ONE |
|
Q1 |
|
|
|
642 |
23474782900 |
Herdiman T. Pohan |
Prof. dr. Herdiman T. Pohan, DTM&H., SpPD(K) |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Clinical Evaluation of HIV/AIDS Patients on Antiretroviral Therapy using HIV Symptoms Index: A reliability and Applicability Evaluation using Indonesian Language |
Shidiq K.M., Nelwan E.J., Yunihastuti E., Harimurti K., Pohan H.T. |
Acta medica Indonesiana |
|
Q3 |
|
|
|
475 |
23475122400 |
Ikhwan Rinaldi |
Dr. dr. Ikhwan Rinaldi, Sp.PD(K). |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Rare case of multiple lineage dysplasia myelodysplastic syndrome presenting with only anemia: A case report |
Soetandyo N., Rinaldi I., Sari R.M., Kosasih A.S., Setiawan L., Winston K. |
Open Access Macedonian Journal of Medical Sciences |
|
Q3 |
|
|
|
500 |
23475122400 |
Ikhwan Rinaldi |
Dr. dr. Ikhwan Rinaldi, Sp.PD(K). |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Diagnosis and Management of Acquired Hemophilia A: Case Reports and a Literature Review |
Rinaldi I., Prasetyawaty F., Fazlines S., Winston K., Samudera Nurrobi Y.A., Leoni J., Restu Tulus Maha I.H., Wicaksono S., Wicaksono A.Y., Aslani A.O., Ikhsani R. |
Case Reports in Medicine |
|
Q4 |
|
|
|
550 |
23475122400 |
Ikhwan Rinaldi |
Dr. dr. Ikhwan Rinaldi, Sp.PD(K). |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Leukapheresis does not improve early survival outcome of acute myeloid leukemia with leukostasis patients ? A dual-center retrospective cohort study |
Rinaldi I., Sari R.M., Tedhy V.U., Winston K. |
Journal of Blood Medicine |
|
Q3 |
|
|
|
583 |
23475122400 |
Ikhwan Rinaldi |
Dr. dr. Ikhwan Rinaldi, Sp.PD(K). |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Does immune checkpoint inhibitor increase the risks of poor outcomes in COVID-19-infected cancer patients? A systematic review and meta-analysis |
Lazarus G., Budiman R.A., Rinaldi I. |
Cancer Immunology, Immunotherapy |
1 |
Q1 |
|
|
|
607 |
23475122400 |
Ikhwan Rinaldi |
Dr. dr. Ikhwan Rinaldi, Sp.PD(K). |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Diagnostic value of neutrophil lymphocyte ratio and D-Dimer as biological markers of deep vein thrombosis in patients presenting with unilateral limb edema |
Rinaldi I., Hamonangan R., Azizi M.S., Cahyanur R., Wirawan F., Fatya A.I., Budiananti A., Winston K. |
Journal of Blood Medicine |
|
Q3 |
|
|
|
669 |
23475122400 |
Ikhwan Rinaldi |
Dr. dr. Ikhwan Rinaldi, Sp.PD(K). |
Departemen Ilmu Penyakit Dalam |
Ilmu Penyakit Dalam (Sp-1) |
Flt3-itd mutation and flt3 ligand plasma level were not associated with one-year survival of Indonesian acute myeloid leukemia patients |
Rinaldi I., Louisa M., Sari R.M., Arwanih E. |
OncoTargets and Therapy |
1 |
Q2 |
|
|
